Rigel Pharmaceuticals Investor Relations Material

Rigel Pharmaceuticals, Inc. is a biotechnology company that discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. Rigel's drug candidates are based on science platforms that target the immune system for therapeutic benefit across a number of different diseases indications. Rigel has a deep pipeline of investigational compounds that have potential to be famous future therapies.